Simplex Trading’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-13,118
| Closed | -$1.18M | – | 9467 |
|
|
2025
Q4 | $1.15M | Buy |
13,118
+10,749
| +454% | +$816K | ﹤0.01% | 2503 |
|
|
2025
Q3 | $135K | Sell |
2,369
-3,351
| -59% | -$193K | ﹤0.01% | 5408 |
|
|
2025
Q2 | $337K | Buy |
+5,720
| New | +$370K | ﹤0.01% | 3929 |
|
|
2025
Q1 | – | Sell |
-5,137
| Closed | -$424K | – | 8899 |
|
|
2024
Q4 | $424K | Buy |
5,137
+2,849
| +125% | +$225K | ﹤0.01% | 3719 |
|
|
2024
Q3 | $163K | Buy |
+2,288
| New | +$162K | ﹤0.01% | 4722 |
|
|
2024
Q2 | – | Sell |
-5,311
| Closed | -$317K | – | 9151 |
|
|
2024
Q1 | $284K | Sell |
5,311
-1,046
| -16% | -$56.2K | ﹤0.01% | 4466 |
|
|
2023
Q4 | $338K | Buy |
+6,357
| New | +$310K | ﹤0.01% | 4098 |
|
|
2023
Q3 | – | Sell |
-509
| Closed | -$28.5K | – | 9066 |
|
|
2023
Q2 | $30K | Sell |
509
-2,224
| -81% | -$127K | ﹤0.01% | 6350 |
|
|
2023
Q1 | $154K | Sell |
2,733
-18,990
| -87% | -$1.22M | ﹤0.01% | 4631 |
|
|
2022
Q4 | $1.61M | Buy |
21,723
+15,415
| +244% | +$1.05M | ﹤0.01% | 2032 |
|
|
2022
Q3 | $375K | Buy |
+6,308
| New | +$380K | ﹤0.01% | 3809 |
|
|
2021
Q4 | – | Sell |
-1,371
| Closed | -$99.5K | – | 10815 |
|
|
2021
Q3 | $107K | Buy |
1,371
+200
| +17% | +$16.1K | ﹤0.01% | 6527 |
|
|
2021
Q2 | $90K | Sell |
1,171
-1,855
| -61% | -$132K | ﹤0.01% | 6876 |
|
|
2021
Q1 | $186K | Buy |
+3,026
| New | +$192K | ﹤0.01% | 4846 |
|
|
2020
Q4 | – | Sell |
-20,157
| Closed | -$1.16M | – | 8588 |
|
|
2020
Q3 | $998K | Buy |
20,157
+2,005
| +11% | +$103K | ﹤0.01% | 2239 |
|
|
2020
Q2 | $866K | Sell |
18,152
-5,567
| -23% | -$269K | ﹤0.01% | 2281 |
|
|
2020
Q1 | $1.01M | Buy |
23,719
+21,732
| +1,094% | +$1.07M | ﹤0.01% | 1878 |
|
|
2019
Q4 | $116K | Sell |
1,987
-707
| -26% | -$38.4K | ﹤0.01% | 4360 |
|
|
2019
Q3 | $137K | Buy |
+2,694
| New | +$128K | ﹤0.01% | 3963 |
|
|
2019
Q1 | – | Sell |
-1,514
| Closed | -$68.5K | – | 7354 |
|
|
2018
Q4 | $65K | Buy |
+1,514
| New | +$75.5K | ﹤0.01% | 4273 |
|
|
2018
Q3 | – | Sell |
-2,940
| Closed | -$155K | – | 7630 |
|
|
2018
Q2 | $148K | Buy |
+2,940
| New | +$153K | ﹤0.01% | 3830 |
|
|
2017
Q4 | – | Sell |
-7,609
| Closed | -$266K | – | 6218 |
|
|
2017
Q3 | $226K | Buy |
7,609
+2,811
| +59% | +$85.8K | 0.01% | 1107 |
|
|
2017
Q2 | $159K | Sell |
4,798
-9,034
| -65% | -$284K | 0.01% | 1373 |
|
|
2017
Q1 | $409K | Sell |
13,832
-5,583
| -29% | -$152K | 0.02% | 791 |
|
|
2016
Q4 | $481K | Buy |
19,415
+9,583
| +97% | +$218K | 0.03% | 565 |
|
|
2016
Q3 | $221K | Buy |
9,832
+8,807
| +859% | +$207K | 0.02% | 961 |
|
|
2016
Q2 | $24K | Sell |
1,025
-18,993
| -95% | -$456K | ﹤0.01% | 2728 |
|
|
2016
Q1 | $475K | Buy |
20,018
+19,983
| +57,094% | +$488K | 0.04% | 468 |
|
|
2015
Q4 | $0 | Buy |
+35
| New | +$879 | ﹤0.01% | 5645 |
|
|
2015
Q3 | – | Sell |
-2,335
| Closed | -$59.1K | – | 5738 |
|
|
2015
Q2 | $59K | Buy |
2,335
+1,019
| +77% | +$25.8K | ﹤0.01% | 1570 |
|
|
2015
Q1 | $33K | Buy |
1,316
+445
| +51% | +$10.8K | ﹤0.01% | 1873 |
|
|
2014
Q4 | $21K | Buy |
+871
| New | +$19.3K | ﹤0.01% | 2007 |
|
Other funds holding GMED
JT
SC
Simplex Trading's GMED Position: Q1 2026 in Review
Simplex Trading sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 13,118 shares — an estimated $1.18M sold.
Simplex Trading first reported a position in GMED in Q4 2014 and held it in 32 quarters. The position peaked at $1.61M in Q4 2022. 607 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Simplex Trading reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 13,118 Globus Medical shares in Q1 2026, an estimated $1.18M.
- Simplex Trading first reported a position in Globus Medical in Q4 2014 and held it in 32 quarters.
- Simplex Trading's Globus Medical position peaked at $1.61M in Q4 2022.
- 607 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.